JP2018515510A5 - - Google Patents

Download PDF

Info

Publication number
JP2018515510A5
JP2018515510A5 JP2017558467A JP2017558467A JP2018515510A5 JP 2018515510 A5 JP2018515510 A5 JP 2018515510A5 JP 2017558467 A JP2017558467 A JP 2017558467A JP 2017558467 A JP2017558467 A JP 2017558467A JP 2018515510 A5 JP2018515510 A5 JP 2018515510A5
Authority
JP
Japan
Prior art keywords
configuration
subject
heart failure
incorporated
polynucleotide vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017558467A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018515510A (ja
Filing date
Publication date
Priority claimed from CN201510232415.6A external-priority patent/CN106177992A/zh
Application filed filed Critical
Publication of JP2018515510A publication Critical patent/JP2018515510A/ja
Publication of JP2018515510A5 publication Critical patent/JP2018515510A5/ja
Pending legal-status Critical Current

Links

JP2017558467A 2015-05-08 2016-06-14 cMLCK遺伝子導入 Pending JP2018515510A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNCN201510232415.6 2015-05-08
CN201510232415.6A CN106177992A (zh) 2015-05-08 2015-05-08 cMLCK基因导入
PCT/CN2016/085699 WO2016180377A1 (zh) 2015-05-08 2016-06-14 cMLCK基因导入

Publications (2)

Publication Number Publication Date
JP2018515510A JP2018515510A (ja) 2018-06-14
JP2018515510A5 true JP2018515510A5 (https=) 2019-07-11

Family

ID=57247711

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017558467A Pending JP2018515510A (ja) 2015-05-08 2016-06-14 cMLCK遺伝子導入

Country Status (10)

Country Link
US (1) US20180133291A1 (https=)
EP (1) EP3295959A4 (https=)
JP (1) JP2018515510A (https=)
KR (1) KR20190008511A (https=)
CN (3) CN106177992A (https=)
AU (1) AU2016260473A1 (https=)
BR (1) BR112017024065A2 (https=)
CA (1) CA2985396A1 (https=)
RU (1) RU2017142779A (https=)
WO (1) WO2016180377A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013053076A1 (en) 2011-10-10 2013-04-18 Zensun (Shanghai)Science & Technology Limited Compositions and methods for treating heart failure
AU2012392119B2 (en) 2012-10-08 2018-07-26 Zensun (Shanghai) Science & Technology, Co. Ltd. Compositions and methods for treating heart failure in diabetic patients
CN106177992A (zh) * 2015-05-08 2016-12-07 上海泽生科技开发有限公司 cMLCK基因导入
CN115838437A (zh) * 2022-11-04 2023-03-24 广州达安基因股份有限公司 人NT-proBNP融合蛋白及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7375185B2 (en) * 2000-09-12 2008-05-20 The United States Of America As Represented By The Department Of Health And Human Services Cardiac myosin light chain kinase polypeptide, encoding nucleic acid, and methods of use
US9580515B2 (en) * 2006-08-21 2017-02-28 Zensun (Shanghai) Science & Technology, Co., Ltd. Neukinase, a downstream protein of neuregulin
JP2009242388A (ja) * 2008-03-14 2009-10-22 National Cardiovascular Center 心臓特異的キナーゼの心不全診断および治療への応用
CN102416184A (zh) * 2011-12-08 2012-04-18 哈尔滨医科大学 microRNA-1的反义锁核苷酸序列在制备预防或治疗心肌梗死后心衰药物中的应用
CN106177992A (zh) * 2015-05-08 2016-12-07 上海泽生科技开发有限公司 cMLCK基因导入

Similar Documents

Publication Publication Date Title
JP2017158561A5 (https=)
JP2018515510A5 (https=)
JP2016529229A5 (https=)
JP2019523648A5 (https=)
RU2019100525A (ru) Векторная система на основе аденоассоциированного вируса
JPWO2019156137A5 (https=)
JP2017532966A5 (https=)
JP2019519528A5 (https=)
RU2014103288A (ru) Слитые полипептиды релаксина и их применение
WO2015150914A3 (en) Systemic delivery of virus vectors encoding urocortin-2 and related genes to treat diabetes-related cardiac dysfunction and congestive heart failure
JP2023534127A5 (https=)
JP2019518073A5 (https=)
IL308645A (en) Viral vectors comprising rdh12 coding regions and methods of treating retinal dystrophies
JP2018533970A5 (https=)
EP3778629B1 (en) Application of ryr2 protein or recombinant ryr2 protein in preparing anti-heart failure medicament
JP2017519765A5 (https=)
RU2017142779A (ru) Перенос гена cmlck
JP2024545186A5 (https=)
JP2020518613A5 (https=)
WO2023178337A3 (en) Methods and compositions for treating rbm20 related cardiomyopathy with a viral vector
JP2023534647A5 (https=)
EP4282490A3 (en) Fibronectin-binding peptides for use in tumor or fibrosis diagnosis and therapy
WO2015108856A3 (en) Methods for enhancing the delivery of active agents
JP2020535203A5 (https=)
CN109306011B (zh) 靶向RyR2蛋白的胞内纳米抗体在制备抗心力衰竭药物中的用途